InfoBionic hires Stuart Long as CEO

Stuart Long, a veteran medical device executive, has been hired as CEO of InfoBionic.

The company announced the news on April 4.

In March 2016, InfoBionic received 510(k) clearance for MoMe Kardia, a cloud-based, wireless remote monitoring system that physicians can use to diagnose cardiac arrhythmias. The company also plans on developing patient monitoring devices for other chronic diseases.

Long was previously the CEO at Monarch Medical Systems, an artificial intelligence clinical decision support software provider for insulin dosing calculations. He has also worked for several other companies, including Philips Healthcare, Agfa Healthcare, FujiFilm and Eastman Kodak.

InfoBionic, which was incorporated in 2011, is a privately held company with headquarters in Lowell, Massachusetts. The company’s investors include Safeguard Scientific, Excel Venture Management, Zaffre Investments and various individuals.

“InfoBionic is redefining the ‘standard of care’ for patients and physicians alike with its remote, full-disclosure cardiac monitoring platform,” Al Wiegman, InfoBionic’s chairman, said in a news release. “The Company has demonstrated traction with an influential base of cardiologists and electrophysiologists since receiving FDA approval last year, yet will benefit from Stuart’s extensive leadership skills and expertise in medical devices and digital health as the company looks to scale-up commercialization and expand its operations. We are bullish on the opportunity that lies ahead for InfoBionic and look forward to supporting the team as it continues to push the boundaries on innovation.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.